Tempus ECG-AF vs Us2.ai
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tempus ECG-AF and Us2.ai are adjacent healthcare-AI tools, both operating within cardiology but addressing different diagnostic modalities and clinical questions. Tempus ECG-AF specializes in predicting the risk of atrial fibrillation using 12-lead ECGs, while Us2.ai automates the comprehensive analysis of echocardiograms for a broader range of cardiac conditions. Therefore, they are not direct competitors but offer complementary AI-driven support.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Tempus ECG-AF is an AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months. Us2.ai is an AI software that automates echocardiogram analysis, generating structured reports and detecting various cardiac conditions such as cardiac amyloidosis, heart failure, aortic stenosis, and pulmonary hypertension.
Tempus ECG-AF analyzes 12-lead ECG recordings and is compatible with FDA authorized resting 12-lead ECGs from GE Medical Systems and Philips Medical Systems. Us2.ai processes echocardiograms and integrates with PACS, CVIS, EMR, and ultrasound devices using DICOM and HL7.
Tempus ECG-AF is intended for patients 65 years or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery. Us2.ai is indicated for use in adult patients and supports every stage of cardiac care, from screening to diagnosis to follow-up.
Tempus ECG-AF provides results indicating an increased risk or no increased risk of new-onset AF within 12 months, which should be interpreted in conjunction with other diagnostic information and clinical history. Us2.ai generates fully automated, zero-click structured echocardiogram reports with comprehensive measurements and automated disease detection.
Tempus ECG-AF is a software solution integrated into healthcare facility systems with advanced cardiology algorithms. Us2.ai offers cloud or on-premise deployment options and integrates with PACS, CVIS, EMR, and ultrasound devices via DICOM and HL7, designed for seamless integration without workflow disruption.
Tempus ECG-AF specifically identifies patients at increased risk of developing new-onset atrial fibrillation/flutter within 12 months. Us2.ai provides automated disease detection for conditions such as cardiac amyloidosis, heart failure, aortic stenosis, and pulmonary hypertension, along with comprehensive automated measurements.